Literature DB >> 10998459

Intestinal fatty acid binding protein polymorphism at codon 54 is not associated with postprandial responses to fat and glucose tolerance tests in healthy young Europeans. Results from EARS II participants.

E Tahvanainen1, M Molin, S Vainio, L Tiret, V Nicaud, E Farinaro, L Masana, C Ehnholm.   

Abstract

UNLABELLED: Polymorphism Ala54Thr of the intestinal fatty acid-binding protein 2 (FABP2) has been reported to have an effect on the protein's affinity for long chain fatty acids and to be associated with serum lipid and insulin levels in fasting and especially postprandial states. We wanted to test whether this genetic variation is associated with fasting and postprandial glucose, insulin or lipid levels in 666 male university students participating in the second European Atherosclerosis Study (EARS II). We also studied whether the subgroup of 330 students with paternal history of myocardial infarction (MI) before the age of 55 have different genotype distribution than 336 matched controls.
RESULTS: No difference in genotype distribution was observed between offspring with and without paternal history of MI or between populations from 11 European countries. The frequency of the threonine encoding allele was 0.276 in cases and 0.266 in controls. There were no differences in fasting or postprandial serum lipid, glucose or insulin levels between subjects having different genotypes.
CONCLUSIONS: In this study FABP2 Ala54Thr polymorphism was not associated with lipid or glucose metabolism. In addition to environmental and genetic factors, selection of study population also may explain the difference between this and earlier studies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10998459     DOI: 10.1016/s0021-9150(99)00488-8

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  8 in total

Review 1.  Liver fatty acid-binding protein and obesity.

Authors:  Barbara P Atshaves; Gregory G Martin; Heather A Hostetler; Avery L McIntosh; Ann B Kier; Friedhelm Schroeder
Journal:  J Nutr Biochem       Date:  2010-11       Impact factor: 6.048

2.  Similar mechanisms of fatty acid transfer from human anal rodent fatty acid-binding proteins to membranes: liver, intestine, heart muscle, and adipose tissue FABPs.

Authors:  Judith Storch; Jacques H Veerkamp; Kuo-Tung Hsu
Journal:  Mol Cell Biochem       Date:  2002-10       Impact factor: 3.396

3.  The association between the FABP2 Ala54Thr variant and the risk of type 2 diabetes mellitus: a meta-analysis based on 11 case-control studies.

Authors:  Peng Liu; Dan Yu; Xiaoping Jin; Cai Li; Feng Zhu; Zhou Zheng; Chenlin Lv; Xinwei He
Journal:  Int J Clin Exp Med       Date:  2015-04-15

4.  Ala54Thr polymorphism of the fatty acid binding protein 2 gene and saturated fat intake in relation to lipid levels and insulin resistance: the Coronary Artery Risk Development in Young Adults (CARDIA) study.

Authors:  Alanna M Chamberlain; Pamela J Schreiner; Myriam Fornage; Catherine M Loria; David Siscovick; Eric Boerwinkle
Journal:  Metabolism       Date:  2009-06-18       Impact factor: 8.694

5.  Variation in the FABP2 promoter alters transcriptional activity and is associated with body composition and plasma lipid levels.

Authors:  Coleen M Damcott; Eleanor Feingold; Susan P Moffett; M Michael Barmada; Julie A Marshall; Richard F Hamman; Robert E Ferrell
Journal:  Hum Genet       Date:  2003-03-13       Impact factor: 4.132

6.  Postprandial Hypertriglyceridemia Is Associated with the Variant 54 Threonine FABP2 Gene.

Authors:  María Fatima Garcés Da Silva; Yamil Adrian Guarin; Yenny Carrero; Hilda Stekman; María Luisa Núñez Bello; Celsy Hernández; Rafael Apitz; Mercedes Fernández-Mestre; Germán Camejo
Journal:  J Cardiovasc Dev Dis       Date:  2018-09-13

7.  Quantile-dependent expressivity of postprandial lipemia.

Authors:  Paul T Williams
Journal:  PLoS One       Date:  2020-02-26       Impact factor: 3.240

8.  Polymorphism of the FABP2 gene: a population frequency analysis and an association study with cardiovascular risk markers in Argentina.

Authors:  Laura C Gomez; Sebastián M Real; Marta S Ojeda; Sergio Gimenez; Luis S Mayorga; María Roqué
Journal:  BMC Med Genet       Date:  2007-06-26       Impact factor: 2.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.